(EMAILWIRE.COM, February 27, 2019 ) Growth in this market is largely driven by the rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries.

Old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2018.

On the basis of type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2018, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to the large number of plain old balloon angioplasty (POBA) procedures carried out across the globe.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

Atherectomy devices segment accounted for the largest share of the plaque modification devices market in 2018.

On the basis of type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2018, the atherectomy devices segment accounted for the largest share of the plaque modification devices market, mainly due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity.

North America accounted for the largest share of the peripheral vascular devices market in 2018.

North America accounted for the largest share of the peripheral vascular market in 2018. The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region.

Some of the major players in the peripheral vascular devices market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

Read the Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com